Ehrendingen, Switzerland

Johannes Schilling

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Johannes Schilling: Innovator in Designed Ankyrin Repeat Domains

Introduction

Johannes Schilling, an inventive mind hailing from Ehrendingen, Switzerland, has made significant strides in the field of biotechnology. His focus lies in the innovative design of ankyrin repeat domains, which are pivotal in a variety of biological applications.

Latest Patents

Schilling holds a patent for his groundbreaking work titled "Designed ankyrin repeat domains with altered surface residues." This invention relates to engineered ankyrin repeat domains featuring modified surface residues, in addition to proteins, nucleic acids, and pharmaceutical compositions associated with these domains. His contributions aim to enhance therapeutic options for treating diseases, showcasing his dedication to advancing medical science.

Career Highlights

Currently, Johannes Schilling is affiliated with Molecular Partners AG, where he continues to push the boundaries of scientific research and innovation. His career is marked by a commitment to developing practical applications of his discoveries, solidifying his reputation as an influential inventor in the biotechnology sector.

Collaborations

Schilling collaborates with esteemed colleagues, including Hans Kaspar Binz and Patrik Forrer. Their collective expertise further enriches the research landscape in which they operate, fostering an environment of synergy and innovation.

Conclusion

Johannes Schilling stands out as a prominent inventor, thanks to his unique contributions to the understanding and application of ankyrin repeat domains. His work at Molecular Partners AG and collaborations with fellow researchers illustrate his significant impact on the biotechnology field, paving the way for future innovations in the treatment of diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…